GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Net Income From Continuing Operations

Olympus (Olympus) Net Income From Continuing Operations : $2,718 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Olympus Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Olympus's net income from continuing operations for the three months ended in Mar. 2024 was $20 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was $2,718 Mil.


Olympus Net Income From Continuing Operations Historical Data

The historical data trend for Olympus's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Net Income From Continuing Operations Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 722.58 223.87 1,263.93 1,419.28 2,563.97

Olympus Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 362.12 2,598.63 -136.05 235.50 20.01

Olympus Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,718 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus (Olympus) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (Olympus) Headlines

From GuruFocus

David Herro Comments on Olympus Corp.

By Holly LaFon 04-23-2013

David Herro's Oakmark International Fund Q1 2013 Commentary

By Holly LaFon Holly LaFon 04-23-2013

Matthews Japan Fund Comments on Olympus

By Sydnee Gatewood Sydnee Gatewood 01-25-2021

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

By ACN Newswire ACN Newswire 12-05-2022

David Herro Comments on Olympus

By Vera Yuan Vera Yuan 10-07-2014

David Herro's Oakmark International Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-08-2020